Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine
Rong-Jian Liu, Catharine H. Duman, T. KATO, et al.
Neuropsychopharmacology (2016) Vol. 42, Iss. 6, pp. 1231-1242
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Mechanisms of ketamine action as an antidepressant
Panos Zanos, Todd D. Gould
Molecular Psychiatry (2018) Vol. 23, Iss. 4, pp. 801-811
Open Access | Times Cited: 904
Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
Ronald S. Duman, Gerard Sanacora, John H. Krystal
Neuron (2019) Vol. 102, Iss. 1, pp. 75-90
Open Access | Times Cited: 785
Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model
Rebecca B. Price, Ronald S. Duman
Molecular Psychiatry (2019) Vol. 25, Iss. 3, pp. 530-543
Open Access | Times Cited: 485
Dendritic structural plasticity and neuropsychiatric disease
Marc P. Forrest, Euan Parnell, Peter Penzes
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 4, pp. 215-234
Open Access | Times Cited: 424
Targeting glutamate signalling in depression: progress and prospects
James W. Murrough, Chadi G. Abdallah, Sanjay J. Mathew
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 7, pp. 472-486
Closed Access | Times Cited: 413
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
Kenji Hashimoto
Psychiatry and Clinical Neurosciences (2019) Vol. 73, Iss. 10, pp. 613-627
Open Access | Times Cited: 287
Stress-Induced Neuronal Colony Stimulating Factor 1 Provokes Microglia-Mediated Neuronal Remodeling and Depressive-like Behavior
Eric S. Wohleb, Rosemarie Terwilliger, Catharine H. Duman, et al.
Biological Psychiatry (2017) Vol. 83, Iss. 1, pp. 38-49
Open Access | Times Cited: 245
The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
Chadi G. Abdallah, Gerard Sanacora, Ronald S. Duman, et al.
Pharmacology & Therapeutics (2018) Vol. 190, pp. 148-158
Open Access | Times Cited: 199
Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics
David E. Olson
Journal of Experimental Neuroscience (2018) Vol. 12
Open Access | Times Cited: 186
Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide
Ronald S. Duman
F1000Research (2018) Vol. 7, pp. 659-659
Open Access | Times Cited: 178
Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex
Amanda J. Sales, Manoela V. Fogaça, Ariandra Guerini Sartim, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 2, pp. 1070-1081
Closed Access | Times Cited: 172
Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine
Satoshi Deyama, Ronald S. Duman
Pharmacology Biochemistry and Behavior (2019) Vol. 188, pp. 172837-172837
Open Access | Times Cited: 150
Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine
Kenichi Fukumoto, Manoela V. Fogaça, Rong-Jian Liu, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 116, Iss. 1, pp. 297-302
Open Access | Times Cited: 161
Convergent Mechanisms Underlying Rapid Antidepressant Action
Panos Zanos, Scott M. Thompson, Ronald S. Duman, et al.
CNS Drugs (2018) Vol. 32, Iss. 3, pp. 197-227
Open Access | Times Cited: 156
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
Bashkim Kadriu, Laura Musazzi, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 2, pp. 119-135
Open Access | Times Cited: 147
Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
Ronald S. Duman, Ryota Shinohara, Manoela V. Fogaça, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 12, pp. 1816-1832
Open Access | Times Cited: 129
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
Marc S. Lener, Bashkim Kadriu, Carlos A. Zarate
Drugs (2017) Vol. 77, Iss. 4, pp. 381-401
Open Access | Times Cited: 124
Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial
Jerome H. Taylor, Angeli Landeros‐Weisenberger, Catherine G. Coughlin, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 2, pp. 325-333
Open Access | Times Cited: 118
Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
Todd D. Gould, Carlos A. Zarate, Scott M. Thompson
The Annual Review of Pharmacology and Toxicology (2018) Vol. 59, Iss. 1, pp. 213-236
Open Access | Times Cited: 117
Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor
Satoshi Deyama, Eunyoung Bang, T. KATO, et al.
Biological Psychiatry (2018) Vol. 86, Iss. 2, pp. 143-152
Open Access | Times Cited: 98
Cell-type specific modulation of NMDA receptors triggers antidepressant actions
Santosh Pothula, T. KATO, Rong-Jian Liu, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 9, pp. 5097-5111
Closed Access | Times Cited: 71
Synaptic Mechanisms Regulating Mood State Transitions in Depression
Puja K. Parekh, Shane B. Johnson, Conor Liston
Annual Review of Neuroscience (2022) Vol. 45, Iss. 1, pp. 581-601
Open Access | Times Cited: 64
Ketamine and the Future of Rapid-Acting Antidepressants
Lace M. Riggs, Todd D. Gould
Annual Review of Clinical Psychology (2021) Vol. 17, Iss. 1, pp. 207-231
Open Access | Times Cited: 62
BDNF release and signaling are required for the antidepressant actions of GLYX-13
T. KATO, Manoela V. Fogaça, Satoshi Deyama, et al.
Molecular Psychiatry (2017) Vol. 23, Iss. 10, pp. 2007-2017
Open Access | Times Cited: 84
N-Methyl-D-aspartate receptor antagonist d-methadone produces rapid, mTORC1-dependent antidepressant effects
Manoela V. Fogaça, Kenichi Fukumoto, Tina Franklin, et al.
Neuropsychopharmacology (2019) Vol. 44, Iss. 13, pp. 2230-2238
Open Access | Times Cited: 73
Page 1 - Next Page

Scroll to top